Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02154321
NCT02154321
Withdrawn
Not Applicable

EEG and ADHD Study

University of Michigan1 site in 1 countryFebruary 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAttention Deficit Hyperactivity DisorderHealthy Controls

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
University of Michigan
Locations
1
Primary Endpoint
Brain Wave Measurements
Status
Withdrawn
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this research is to assess and determine brain oscillations or "brain signatures" of adult participants with Attention Deficit Hyperactivity Disorder (ADHD) relative to adult participants without ADHD using the technique electroencephalogram (EEG). Electroencephalogram is entirely non-invasive way of tracking brain activity.The main goal of this study is to establish biological factors for determining the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD).

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
September 15, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chandra Sekhar Sripada

Chandra Sekhar Sripada, MD, PhD

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Brain Wave Measurements

Time Frame: Two years

Measurement of electroencephalogram amplitude and coherence in alpha, gamma, and theta brain wave bands.

Secondary Outcomes

  • Default Network Signatures(two years)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 4
Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response PotentialsAttention Deficit Hyperactivity Disorder
NCT01063153Massachusetts General Hospital71
Completed
Phase 1
Biomarkers of ADHD Treatment ResponseADHD
NCT05650775Boston Children's Hospital16
Unknown
Not Applicable
Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity DisorderAttention Deficit Hyperactivity Disorder
NCT00143767UMC Utrecht400
Unknown
Not Applicable
Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment"Attention Deficit Hyperactivity Disorder"
NCT01962181Hadassah Medical Organization40
Active, not recruiting
Phase 1
AD/HD diagnosis through EEG, a pilot studyAttention Deficit - Hyperactivity Disorder (AD/HD)MedDRA version: 8.1Level: LLTClassification code 10003735Term: Attention deficit-hyperactivity disorder
EUCTR2006-002716-94-ISMentis Cura ehf.80